In this video, we put Shire‘s (LSE: SHP) deal with AbbVie (NYSE: ABBV) under the spotlight. For each share they held in Shire, investors will receive a cash consideration of £24.44 as well as 0.8960 new AbbVie shares. Here, two Fools look at whether investors should jump into either — or neither — of the pharmaceutical companies.
A Closer Look At Shire PLC
VIDEO: Two Fools take a closer look at Shire PLC (LON:SHP).
The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.
You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.